Erratum: The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study (Annals of Hematology (1992) 65 (162-168))K. Miller, M J O'Connell, Francis S. Morrison et al.|Unknown|1993Cited by 2